Brightmeds vs NextMeds
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Brightmeds
Best for: knowing which pharmacy fills the vial — it names Beaker Pharmacy
Visit Brightmeds →
NextMeds
Best for: semaglutide at $79/month, 59% under the register median
Visit NextMeds →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, NextMeds opens cheaper — $79/mo against $100, and NextMeds finishes ahead, 9.2 to 8.4. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Brightmeds
'Starting at $189' is the only published sema price (1-month plan per on-page comparison chart); ongoing/renewal price NOT published anywhere on public pages as of 2026-07-14 — the '$333/mo therafter' card verified 2026-06-06 has been removed. 'Save $50 on our First Order' banner active.
'Starting at $289' shown on the sema lander card and in the tirz lander's pricing-comparison image ('Tirzepatide (1-Month) $289 — Best Price! 1-Month Plan'); the tirz lander TEXT now contains no dollar prices at all — both the old '$249/mo' hero and '$397/mo therafter' card are gone. Ongoing price quiz-gated = not published.
Unchanged — page title verbatim 'Brightmeds: Choose Your TRT Goal: $75 Per Week, Free Labs'. TRT side-effect disclosures now also cover Enclomiphene and Anastrozole (new adjunct meds).
/products verbatim: '$100 Brightmeds doctor consult fee — Prescription sent to LillyDirect® or your preferred local pharmacy — You'll pay the pharmacy directly (price may vary by pharmacy)'; vials 'Medication cost is billed separately by LillyDirect®'. Drug price not published by Brightmeds.
NextMeds
Compounded Semaglutide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $79 is the month-to-month rate read from the pricing section on 2026-08-14. The site headline reads 'from $49/mo': that is the 12-month prepaid term divided down, not a monthly price, and the ladder between them is 3-month $76, 6-month $73, 12-month $49. A summer promotion was running with a stated end of August 20, so $79 may itself be discounted.
Compounded Tirzepatide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $109 is the month-to-month rate read from the pricing section on 2026-08-14. The advertised 'GLP-1 + GIP: $95' is the 12-month prepaid term divided down; the ladder is 3-month $105, 6-month $100, 12-month $95. A summer promotion was running with a stated end of August 20, so $109 may itself be discounted.
What’s included
Brightmeds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
Not stated
NextMeds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Brightmeds
8.4/10
NextMeds
9.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Brightmeds | NextMeds |
|---|---|---|
| Starting Price | $100/mo | ✓$79/mo |
| Features | 8 features | 8 features |
| States Available | 47 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warnings | None | None |
About Brightmeds
Compounded semaglutide opens at $189/mo, with tirzepatide at $289/mo, priced flat whatever the dose, but what renewal costs later is not published until the intake quiz is done. A single membership spans longevity peptides (sermorelin, NAD+, glutathione), TRT aimed at men, and GLP-1 weight loss. Both modalities are stocked, compounded drugs with microdosing protocols included and branded Zepbound in pens and vials, a mix rarely seen. 47 states are served.
Read our full Brightmeds review →About NextMeds
Membership is a single flat monthly charge, and inside it sit free shipping, a registered dietitian holding a license, a care coach working 1:1, telehealth visits and the drug itself where one is prescribed. Insurance is not billed. A free assessment online goes to a licensed provider, who adds a phone or video consult in states that demand one, then prescribes if it fits. Compounding pharmacies within the Next Meds network, all licensed, ship. Auto-renewal does not exist, cancellation is open, and all 50 states can order compounded tirzepatide and semaglutide.
Read our full NextMeds review →Pros & Cons
Brightmeds
What we like
- Tirzepatide at $100 a month, 63% below the $267 median for the same drug and form across this register
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping, labs
- Coverage is published for 47 states
- Names 2 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
NextMeds
What we like
- Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- Tirzepatide at $109 a month, 59% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping, coaching
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
NextMeds takes it, 9.2 against 8.4, and it is especially strong on semaglutide at $79/month, 59% under the register median. Brightmeds is no weak second and may fit you better on knowing which pharmacy fills the vial — it names Beaker Pharmacy.
Choose Brightmeds if…
You want knowing which pharmacy fills the vial — it names Beaker Pharmacy and an opening price near $100 a month.
Choose NextMeds if…
You want semaglutide at $79/month, 59% under the register median and an opening price near $79 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Oak
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Direct Meds
Compounded semaglutide at $249/month
From $249/mo
Get started →Try Ageless
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Brightmeds vs NextMeds: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Brightmeds and NextMeds head-to-heads in the same category.
- Brightmeds vs Trimi Health
- Brightmeds vs Embody
- Brightmeds vs He & She MD
- NextMeds vs Lean Meds
- NextMeds vs bmiMD
- NextMeds vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.